These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1687 related items for PubMed ID: 6329988

  • 1. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW, Demsey A.
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [Abstract] [Full Text] [Related]

  • 2. Syngeneic monoclonal antibodies to B16 melanoma viral antigens.
    Rappaport I, Alterman AL, Braverman S, Stackpole CW.
    Cancer Res; 1987 Oct 15; 47(20):5391-6. PubMed ID: 3652042
    [Abstract] [Full Text] [Related]

  • 3. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R, Graziano RF, Green WR.
    J Immunol; 1986 Mar 15; 136(6):2271-9. PubMed ID: 3005407
    [Abstract] [Full Text] [Related]

  • 4. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ, Hearn DR.
    Cancer Res; 1983 Nov 15; 43(11):5106-11. PubMed ID: 6616449
    [Abstract] [Full Text] [Related]

  • 5. Identification of immunogenic B16 melanoma-associated antigens.
    Johnston D, Schachne JP, Bystryn JC.
    J Biol Response Mod; 1987 Apr 15; 6(2):108-20. PubMed ID: 3585408
    [Abstract] [Full Text] [Related]

  • 6. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR, Brown MA.
    Eur J Immunol; 1983 Nov 15; 13(11):871-7. PubMed ID: 6196207
    [Abstract] [Full Text] [Related]

  • 7. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B, Manohar V, Sugimoto T, Ashley MP, Kato Y, Rappaport P.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [Abstract] [Full Text] [Related]

  • 8. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ, Wheelock EF.
    Cancer Res; 1982 Sep 15; 42(9):3607-16. PubMed ID: 6179603
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
    Fidler IJ, Bucana C.
    Cancer Res; 1977 Nov 15; 37(11):3945-56. PubMed ID: 908034
    [Abstract] [Full Text] [Related]

  • 10. Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding beta-galactosidase fused to an envelope protein of endogenous retrovirus.
    Takeda J, Sato Y, Kiyosawa H, Mori T, Yokoya S, Irisawa A, Miyata M, Obara K, Fujita T, Suzuki T, Kasukawa R, Wanaka A.
    Cell Immunol; 2000 Aug 25; 204(1):11-8. PubMed ID: 11006013
    [Abstract] [Full Text] [Related]

  • 11. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC, Abrams JT, Zhang SY, Galili U.
    Cancer Res; 1999 Jul 15; 59(14):3417-23. PubMed ID: 10416604
    [Abstract] [Full Text] [Related]

  • 12. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
    Herd ZL.
    Cancer Res; 1987 May 15; 47(10):2696-703. PubMed ID: 3552203
    [Abstract] [Full Text] [Related]

  • 13. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec 15; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 14. Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.
    Hearing VJ, Gersten DM, Montague PM, Vieira WD, Galetto G, Law LW.
    J Immunol; 1986 Jul 01; 137(1):379-84. PubMed ID: 3711669
    [Abstract] [Full Text] [Related]

  • 15. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T, Gonzalez R, Nicolson GL.
    Cancer Res; 1981 Sep 01; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [Abstract] [Full Text] [Related]

  • 16. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R, Kennel SJ, Giacomini P, Zupi G, Sacchi A.
    Cancer Res; 1986 Nov 01; 46(11):5772-8. PubMed ID: 3756921
    [Abstract] [Full Text] [Related]

  • 17. Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70.
    Grohmann U, Ullrich SJ, Mage MG, Appella E, Fioretti MC, Puccetti P, Romani L.
    Eur J Immunol; 1990 Mar 01; 20(3):629-36. PubMed ID: 2318253
    [Abstract] [Full Text] [Related]

  • 18. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
    Parratto NP, Odebralski JM, Kimura AK.
    Cancer Res; 1989 Jul 15; 49(14):3722-8. PubMed ID: 2736512
    [Abstract] [Full Text] [Related]

  • 19. [Xenogeneic melanoma-related antigen elicits anti-tumor immune response, companied by autoimmune injury].
    Tan XH, Wan YH.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 22; 85(23):1596-600. PubMed ID: 16185524
    [Abstract] [Full Text] [Related]

  • 20. Development of host immunity to phenotypically diverse B16 melanoma clones. Implications for tumor growth and metastasis.
    Stackpole CW, Alterman AL, Braverman S, Rappaport I.
    Invasion Metastasis; 1987 Jun 22; 7(6):346-66. PubMed ID: 3436737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.